Germline polymorphism at the β2‐microglobulin exon 1/intron 1 splice site in canine mammary gland simple and complex carcinomas
2013; Wiley; Volume: 172; Issue: 20 Linguagem: Inglês
10.1136/vr.101238
ISSN2042-7670
AutoresToshiyuki Tanaka, T Shimada, Hideo Akiyoshi, Cao Zheng, Keiichiro Mie, Yijyun Li, A. Hayashi, Fumihito Ohashi,
Tópico(s)T-cell and B-cell Immunology
ResumoVeterinary RecordVolume 172, Issue 20 p. 529-529 Research Germline polymorphism at the β2-microglobulin exon 1/intron 1 splice site in canine mammary gland simple and complex carcinomas T. Tanaka DVM, T. Tanaka DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorT. Shimada DVM, PhD, T. Shimada DVM, PhD Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorH. Akiyoshi DVM, PhD, H. Akiyoshi DVM, PhD Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorC. Zheng DVM, C. Zheng DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorK. Mie DVM, K. Mie DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorL. Yijyun DVM, L. Yijyun DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorA. Hayashi DVM, A. Hayashi DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorF. Ohashi DVM, PhD, Advanced Clinical Medicine, Corresponding Author F. Ohashi DVM, PhD, Advanced Clinical Medicine [email protected] Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanE-mail for correspondence: [email protected]Search for more papers by this author T. Tanaka DVM, T. Tanaka DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorT. Shimada DVM, PhD, T. Shimada DVM, PhD Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorH. Akiyoshi DVM, PhD, H. Akiyoshi DVM, PhD Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorC. Zheng DVM, C. Zheng DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorK. Mie DVM, K. Mie DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorL. Yijyun DVM, L. Yijyun DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorA. Hayashi DVM, A. Hayashi DVM Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanSearch for more papers by this authorF. Ohashi DVM, PhD, Advanced Clinical Medicine, Corresponding Author F. Ohashi DVM, PhD, Advanced Clinical Medicine [email protected] Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-oraikita, Izumisano-shi, Osaka, 598-8531 JapanE-mail for correspondence: [email protected]Search for more papers by this author First published: 18 May 2013 https://doi.org/10.1136/vr.101238Citations: 1 Provenance: Not commissioned; externally peer reviewed Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References Aptsiauri N., Cabrera T., Garcia-Lora A., Lopez-Nevot M. A., Ruiz-Cabello F., Garrido F. (2007) MHC class I antigens and immune surveillance in transformed cells. International Review of Cytology 256, 139–189 Campoli M., Ferrone S. (2008) HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27, 5869–5885 Chang C. C., Campoli M., Ferrone S. (2003) HLA class I defects in malignant lesions: what have we learned? The Keio Journal of Medicine 52, 220–229 Chang C. C., Campoli M., Restifo N. P., Wang X., Ferrone S. (2005) Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. The Journal of Immunology 174, 1462–1471 Chang M. L., Terrill R. L., Bautista M. M., Carlson E. J., Dyer D. J., Overall K. L., Hamilton S. P. (2007) Large-scale SNP genotyping with canine buccal swab DNA. The Journal of Heredity 98, 428–437 Chen H. L., Gabrilovich D., Virmani A., Ratnani I., Girgis K. R., Nadaf-Rahrov S., Fernandez-Viña M., Carbone D. P. (1996) Structural and functional analysis of β2-microglobulin abnormalities in human lung and breast cancer. International Journal of Cancer 67, 756–763 Claes K., Poppe B., Machackova E., Coene I., Foretova L., De Paepe A., Messiaen L. (2003) Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes, Chromosomes & Cancer 37, 314–320 Garrido F., Ruiz-Cabello F., Cabrera T., Pérez-Villar J. J., López-Botet M., Duggan-Keen M., Stern P. L. (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunology Today 18, 89–95 Hansen T. V., Steffensen A. Y., Jønson L., Andersen M. K., Ejlertsen B., Nielsen F. C. (2010) The silent mutation nucleotide 744 G –> A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Research and Treatment 119, 547–550 Hunter K. W., Crawford N. P. (2006) Germ line polymorphism in metastatic progression. Cancer Research 66, 1251–1254 Kloor M., Michel S., Buckowitz B., Rüschoff J., Büttner R., Holinski-Feder E., Dippold W., Wagner R., Tariverdian M., Benner A., Schwitalle Y., Kuchenbuch B., Von Knebel Doeberitz M. (2007) Beta2-microglobulin mutations in microsatellite unstable colorectal tumors. International Journal of Cancer 121, 454–458 Komar A. A. (2007) Genetics. SNPs, silent but not invisible. Science 315, 466–467 Pedersen L. O., Hansen A. S., Olsen A. C., Gerwien J., Nissen M. H., Buus S. (1994) The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigen. Scandinavian Journal of Immunology 39, 64–72 PÉrez B., Benitez R., FernÁndez M. A., Oliva M. R., Soto J. L., Serrano S., López Nevot M. A., Garrido F. (1999) A new beta 2 microglobulin mutation found in a melanoma tumor cell line. Tissue Antigens 53, 569–572 Citing Literature Volume172, Issue20May 2013Pages 529-529 ReferencesRelatedInformation
Referência(s)